𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Development and validation of an in vitro dissolution method for a floating dosage form with biphasic release characteristics

✍ Scribed by S.J. Burns; D. Corness; G. Hay; S. Higginbottom; I. Whelan; D. Attwood; S.G. Barnwell

Book ID
113366603
Publisher
Elsevier Science
Year
1995
Tongue
English
Weight
625 KB
Volume
121
Category
Article
ISSN
0378-5173

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Once-a-day controlled-release dosage for
Once-a-day controlled-release dosage form of divalproex sodium II: Development of a predictive in vitro drug release method
✍ Yihong Qiu; J. Garren; E. Samara; G. Cao; C. Abraham; H.S. Cheskin; K.R. Engh πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 207 KB πŸ‘ 1 views

During formulation design of a once-daily controlled release matrix system of divalproex sodium, the in vitro dissolution test (USP II, 100 rpm, pH 6.8 buffer) was found to result in release rates that were slower than in vivo absorption. The test method also did not sufficiently discriminate formul

Once-a-day extended-release dosage form
Once-a-day extended-release dosage form of divalproex sodium III: Development and validation of a Level A in vitro–in vivo correlation (IVIVC)
✍ Sandeep Dutta; Yihong Qiu; Emil Samara; Guoliang Cao; G. Richard Granneman πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 257 KB πŸ‘ 1 views

Defining a quantitative and reliable relationship between in vitro drug release and in vivo absorption is highly desired for rational development, optimization, and evaluation of controlled-release dosage forms and manufacturing process. During the development of a once-daily extended-release (ER) t